Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C.

JAMA. 2012 Jan 25;307(4):391-7. doi: 10.1001/jama.2011.2034. Erratum in: JAMA. 2012 Mar 21;307(11):1142.

2.

Exposure to brominated flame retardants, perfluorinated compounds, phthalates and phenols in European birth cohorts: ENRIECO evaluation, first human biomonitoring results, and recommendations.

Casas M, Chevrier C, Hond ED, Fernandez MF, Pierik F, Philippat C, Slama R, Toft G, Vandentorren S, Wilhelm M, Vrijheid M.

Int J Hyg Environ Health. 2013 Jun;216(3):230-42. doi: 10.1016/j.ijheh.2012.05.009. Epub 2012 Jul 12. Review.

PMID:
22795704
3.

Perfluorinated compounds in umbilical cord blood and adverse birth outcomes.

Chen MH, Ha EH, Wen TW, Su YN, Lien GW, Chen CY, Chen PC, Hsieh WS.

PLoS One. 2012;7(8):e42474. doi: 10.1371/journal.pone.0042474. Epub 2012 Aug 3.

4.

Human detoxification of perfluorinated compounds.

Genuis SJ, Birkholz D, Ralitsch M, Thibault N.

Public Health. 2010 Jul;124(7):367-75. doi: 10.1016/j.puhe.2010.03.002. Epub 2010 Jun 19.

PMID:
20621793
5.

Exposure to perfluorinated compounds and human semen quality in Arctic and European populations.

Toft G, Jönsson BA, Lindh CH, Giwercman A, Spano M, Heederik D, Lenters V, Vermeulen R, Rylander L, Pedersen HS, Ludwicki JK, Zviezdai V, Bonde JP.

Hum Reprod. 2012 Aug;27(8):2532-40. doi: 10.1093/humrep/des185. Epub 2012 May 30.

6.

Immunotoxicity of perfluorinated compounds: recent developments.

DeWitt JC, Peden-Adams MM, Keller JM, Germolec DR.

Toxicol Pathol. 2012;40(2):300-11. doi: 10.1177/0192623311428473. Epub 2011 Nov 22. Review.

7.

Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study.

Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, Thomsen C, Eggesbo M, Travlos G, Wilson R, Cupul-Uicab LA, Brantsaeter AL, Longnecker MP.

Am J Epidemiol. 2012 Jun 15;175(12):1209-16. doi: 10.1093/aje/kwr459. Epub 2012 Apr 19.

8.

Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds.

Guerrero-Preston R, Goldman LR, Brebi-Mieville P, Ili-Gangas C, Lebron C, Witter FR, Apelberg BJ, Hernández-Roystacher M, Jaffe A, Halden RU, Sidransky D.

Epigenetics. 2010 Aug 16;5(6):539-46. Epub 2010 Aug 16.

9.

Perfluorinated compounds and subfecundity in pregnant women.

Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, Thomsen C, Eggesbo M, Travlos G, Wilson R, Longnecker MP.

Epidemiology. 2012 Mar;23(2):257-63. doi: 10.1097/EDE.0b013e31823b5031.

10.

In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs).

Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, Galli CL, Dell'Agli M, Germolec DR.

Toxicol Appl Pharmacol. 2012 Jan 15;258(2):248-55. doi: 10.1016/j.taap.2011.11.004. Epub 2011 Nov 18.

PMID:
22119708
11.

Health risks of dietary exposure to perfluorinated compounds.

Domingo JL.

Environ Int. 2012 Apr;40:187-95. doi: 10.1016/j.envint.2011.08.001. Epub 2011 Aug 23. Review.

PMID:
21864910
12.

Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones.

Ji K, Kim S, Kho Y, Paek D, Sakong J, Ha J, Kim S, Choi K.

Environ Int. 2012 Sep 15;45:78-85. doi: 10.1016/j.envint.2012.03.007. Epub 2012 May 9.

PMID:
22580293
13.

Perfluorinated compounds--exposure assessment for the general population in Western countries.

Fromme H, Tittlemier SA, Völkel W, Wilhelm M, Twardella D.

Int J Hyg Environ Health. 2009 May;212(3):239-70. doi: 10.1016/j.ijheh.2008.04.007. Epub 2008 Jun 18. Review.

PMID:
18565792
14.

Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study.

Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Krüger T, Ghisari M, Mulvad G, Kern P, Nzulumiki P, Dewailly E.

Environ Health. 2011 Oct 6;10:88. doi: 10.1186/1476-069X-10-88.

15.

Perfluorinated compounds and immunotoxicity in children.

Zobel LR, Olsen GW, Butenhoff JL.

JAMA. 2012 May 9;307(18):1910; author reply 1910-1. doi: 10.1001/jama.2012.3599. No abstract available.

PMID:
22570452
16.

Perfluorinated compounds: occurrence and risk profile.

Kovarova J, Svobodova Z.

Neuro Endocrinol Lett. 2008 Oct;29(5):599-608. Review.

PMID:
18987583
17.

Effects of perfluorinated compounds on development of zebrafish embryos.

Zheng XM, Liu HL, Shi W, Wei S, Giesy JP, Yu HX.

Environ Sci Pollut Res Int. 2011 Aug;19(7):2498-505. doi: 10.1007/s11356-012-0977-y. Epub 2012 Aug 31.

PMID:
22828880
18.

Perfluorinated compounds differentially affect steroidogenesis and viability in the human adrenocortical carcinoma (H295R) in vitro cell assay.

Kraugerud M, Zimmer KE, Ropstad E, Verhaegen S.

Toxicol Lett. 2011 Aug 10;205(1):62-8. doi: 10.1016/j.toxlet.2011.05.230. Epub 2011 May 27.

PMID:
21641976
19.

Levels and trends of poly- and perfluorinated compounds in the arctic environment.

Butt CM, Berger U, Bossi R, Tomy GT.

Sci Total Environ. 2010 Jul 1;408(15):2936-65. doi: 10.1016/j.scitotenv.2010.03.015. Epub 2010 May 20. Review.

PMID:
20493516
20.

In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs).

Corsini E, Avogadro A, Galbiati V, dell'Agli M, Marinovich M, Galli CL, Germolec DR.

Toxicol Appl Pharmacol. 2011 Jan 15;250(2):108-16. doi: 10.1016/j.taap.2010.11.004. Epub 2010 Nov 12.

PMID:
21075133
Items per page

Supplemental Content

Write to the Help Desk